 The purpose of this study is to evaluate safety and preliminary efficacy of Neofusetm in subjects with a diagnosis of degenerative disc disease DDD in 1 or 2 adjacent vertebral levels between L1 and S1 and undergoing posterolateral lumbar fusion. 